Details for New Drug Application (NDA): 209471
✉ Email this page to a colleague
The generic ingredient in COMBOGESIC is acetaminophen; ibuprofen sodium. There are sixty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the acetaminophen; ibuprofen sodium profile page.
Summary for 209471
Tradename: | COMBOGESIC |
Applicant: | Aft Pharms Us |
Ingredient: | acetaminophen; ibuprofen |
Patents: | 3 |
Pharmacology for NDA: 209471
Mechanism of Action | Cyclooxygenase Inhibitors |
Suppliers and Packaging for NDA: 209471
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
COMBOGESIC | acetaminophen; ibuprofen | TABLET;ORAL | 209471 | NDA | Hikma Pharmaceuticals USA Inc | 0143-9432 | 0143-9432-27 | 250 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0143-9432-27) |
COMBOGESIC | acetaminophen; ibuprofen | TABLET;ORAL | 209471 | NDA | AFT Pharmaceuticals US, Inc. | 72260-129 | 72260-129-01 | 250 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72260-129-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 325MG;97.5MG | ||||
Approval Date: | Mar 1, 2023 | TE: | RLD: | Yes | |||||
Regulatory Exclusivity Expiration: | Mar 1, 2026 | ||||||||
Regulatory Exclusivity Use: | NEW PRODUCT | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Sep 22, 2025 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | A METHOD OF TREATING MILD TO MODERATE ACUTE PAIN IN ADULTS BY ADMINISTERING 975-1000 MG OF ACETAMINOPHEN AND 292.5-300 MG OF IBUPROFEN IN A SINGLE ADMINISTRATION | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Feb 27, 2039 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | A METHOD OF TREATING MILD TO MODERATE ACUTE PAIN IN ADULTS BY ADMINISTERING 975-1000 MG OF ACETAMINOPHEN AND 292.5-300 MG OF IBUPROFEN IN A SINGLE ADMINISTRATION |
Complete Access Available with Subscription